Contraline
Manufacturing · Virginia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
818 E Jefferson St Ste 201, Charlottesvi...Phone Number
(434) 218-6668Website
www.contraline.comRevenue
$11.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Contraline
Contraline is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAMTM, a non-hormonal male contraceptive that uses proprietary advancements in hydrogel technology for occlusion of the vas deferens. The company was founded in 2015 and is headquartered in Charlottesville, Virginia.Explore more
Contraline Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Contraline your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Contraline recently announced quarterly report
Website visits: Recent activity has been detected on your website
Contraline, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Contraline
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Contraline had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Contraline has new funding data
Check out if Contraline is spiking on competitors!
Product Launch: Get notified when Contraline launches new products
Check if Contraline has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Contraline
Find 2 more new buyers
Compare Similar Companies to Contraline
Compare insights from companies similar to Contraline, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Contraline is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Contraline is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Contraline.
Contraline financials insights
Gather financial insights about Contraline, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$2.3M
2020
Series A
$6M
2021
Series A
$10.7M
2022
Other Financing Round
$1M
Other Financing Round
$7.2M
2026
Series B
$92.5M
Contraline Tech Stack
A closer look at the technologies used by Contraline
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Facilities Relocation / Expansion
Facilities Relocation/Expansion
New Hire
Executive Move
Funding
Funding
Contraline News & Media
Contraline and its male birth control candidate rally $92.5M amid push into 'massive white ...
Amid shifts in attitudes around family planning and contraception—and as the advent telehealth outfits like Hims & Hers and Ro define a new era of consumer-driven healthcare—the lack of a medic | Recognizing the gap in male birth control, Charlottesville, Virginia’s Contraline is stepping up to the plate, developing what it believes could be a first-in-class topical candidate that has now garnered enthusiasm from a host of big-name investors.Contraline and Population Council Execute Global Exclusive License Agreement for NES/T Male Contraception Gel
Contraline Set to Launch a Historic Phase 3 Clinical Program in Male Contraception NEW YORK, NY, UNITED STATES, February 4, 2026 /EINPresswire.com/ -- Contraline Inc., a clinical-stage biotechnology company, and the Population Council, an international …Contraline Announces 24-Month Safety and Efficacy Results from First-in-Human Trial of ADAM™
CHARLOTTESVILLE, VA, UNITED STATES, April 24, 2025 /EINPresswire.com/ -- Contraline, a clinical-stage male contraception company, today announced that participants in the First-in-Human clinical trial of ADAM™ (“The ADAM Study”) have reached a critical …Contraline & Population Council Announce Option-to-License Agreement for a Revolutionary Male Contraceptive
CHARLOTTESVILLE, Va.--(BUSINESS WIRE)-- #birthcontrol--Contraline, Inc., a clinical-stage biotechnology company, proudly announces the signing of an exclusive option-to-license agreement with the Population Council for the Nestorone/Testosterone Transdermal Gel (NES/T) for male contraception. Upon exercising the option, Contraline will spearhead the global development and commercialization of NES/T, positioning Contraline as the world’s preeminent biotechnology company in male contraception. Con
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Contraline
Sign Up For FreeTo access detailed company insights
Contraline is a venture-backed medical device company devoted to providing men and couples with long-lasting, safe, and effective contraception. The company is developing ADAMTM, a non-hormonal male contraceptive that uses proprietary advancements in hydrogel technology for occlusion of the vas deferens. The company was founded in 2015 and is headq... Read More
